For: | Kodar K, Izotova J, Klaamas K, Sergeyev B, Järvekülg L, Kurtenkov O. Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients. World J Gastroenterol 2013; 19(23): 3573-3582 [PMID: 23801858 DOI: 10.3748/wjg.v19.i23.3573] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i23/3573.htm |
Number | Citing Articles |
1 |
Yi-Ning Li, Ji-An Hu, Hui-Ming Wang. Inhibition of HIF-1αAffects Autophagy Mediated Glycosylation in Oral Squamous Cell Carcinoma Cells. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/239479
|
2 |
Oleg Kurtenkov, Jelena Izotova, Kersti Klaamas, Boris Sergeyev. Increased Sialylation of Anti-Thomsen-Friedenreich Antigen (CD176) Antibodies in Patients with Gastric Cancer: A Diagnostic and Prognostic Potential. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/830847
|
3 |
Kirill Sergejev, Raul Land, Kersti Klaamas, Oleg Kurtenkov. Electrochemical impedance spectroscopy analysis of immunoglobulin G in patients with gastric cancer. 2014 14th Biennial Baltic Electronic Conference (BEC) 2014; : 189 doi: 10.1109/BEC.2014.7320588
|
4 |
Ewa M. Kratz, Mirosława Ferens-Sieczkowska, Ricardo Faundez, Iwona Kątnik-Prastowska. Changes in fucosylation of human seminal IgG and secretory component of IgA in leukocytospermic patients. Glycoconjugate Journal 2014; 31(1): 51 doi: 10.1007/s10719-013-9501-y
|
5 |
Xiang Li, Feng Guan, Dongliang Li, Zengqi Tan, Ganglong Yang, Yanli Wu, Zhaohui Huang. Identification of aberrantly expressed glycans in gastric cancer by integrated lectin microarray and mass spectrometric analyses. Oncotarget 2016; 7(52): 87284 doi: 10.18632/oncotarget.13539
|
6 |
Oleg Kurtenkov, Kersti Klaamas. Hidden IgG Antibodies to the Tumor-Associated Thomsen-Friedenreich Antigen in Gastric Cancer Patients: Lectin Reactivity, Avidity, and Clinical Relevance. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/6097647
|
7 |
Oleg Kurtenkov, Kersti Klaamas. Increased Avidity of theSambucus nigraLectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/761908
|
8 |
Sofia Shkunnikova, Anika Mijakovac, Lucija Sironic, Maja Hanic, Gordan Lauc, Marina Martinic Kavur. IgG glycans in health and disease: Prediction, intervention, prognosis, and therapy. Biotechnology Advances 2023; 67: 108169 doi: 10.1016/j.biotechadv.2023.108169
|
9 |
Radjiv Goulabchand, Thierry Vincent, Frédéric Batteux, Jean-françois Eliaou, Philippe Guilpain. Impact of autoantibody glycosylation in autoimmune diseases. Autoimmunity Reviews 2014; 13(7): 742 doi: 10.1016/j.autrev.2014.02.005
|
10 |
Oleg Kurtenkov, Kaire Innos, Boris Sergejev, Kersti Klaamas. The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/9579828
|
11 |
Danilo do Rosário Pinheiro, Wallax Augusto Silva Ferreira, Mariceli Baia Leão Barros, Mariana Diniz Araújo, Symara Rodrigues-Antunes, Bárbara do Nascimento Borges. Perspectives on new biomarkers in gastric cancer: Diagnostic and prognostic applications. World Journal of Gastroenterology 2014; 20(33): 11574-11585 doi: 10.3748/wjg.v20.i33.11574
|
12 |
Oleg Kurtenkov. Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9747040
|
13 |
Shibu Krishnan, Harry Whitwell, Joy Cuenco, Aleksandra Gentry-Maharaj, Usha Menon, Stephen Pereira, Marco Gaspari, John Timms. Evidence of Altered Glycosylation of Serum Proteins Prior to Pancreatic Cancer Diagnosis. International Journal of Molecular Sciences 2017; 18(12): 2670 doi: 10.3390/ijms18122670
|